Work

Abstract B013: KAT6A/B Inhibition Durably Reprograms Neuroblastoma Cell State to Enhance Retinoid Response and GD2-Directed Immunotherapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.d32026-b013

Authors: Francesca AlvarezCalderon, Ulrike Gerdemann, silvi salhotra, Nathaniel Mabe, Adam Durbin, Brian Abraham, Kimberly Stegmaier, A. Thomas Look, Nina Weichert-Leahey

Institutions: Dana-Farber Cancer Institute, St. Jude Children's Research Hospital

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7169885086

Cites:

Cited by:

Related to: 10